A complete Seed financial model for Healthcare Biotech startups. Revenue model, unit economics, hiring plan, cash flow projections, and funding scenarios — structured for investor review.
Projection Horizon
3 years (monthly for Year 1, quarterly for Years 2-3)
Model Tabs
7 core tabs
Format
Excel + Google Sheets
Path to Series A metrics and the unit economics that prove the business model. Seed investors model the path from current to Series A-level KPIs.
Healthcare models must show revenue cycle efficiency separately from clinical cost. Investors want to see AR days trend, denial rate trend, and payer mix shift over time — not just blended revenue per patient.
Reimbursement-driven revenue model with payer mix, reimbursement rates, and billing collection efficiency. Model patient volume ramp separately from revenue per patient as payer mix shifts.
Seed models should have a clearly documented assumption page. Every assumption should include a source (comparable company benchmark, customer interview data, or market research). Avoid top-down market share assumptions.
Show base case (on-plan), downside (50% of plan), and recovery timeline from downside. Include a Series A readiness milestone tracker showing the KPIs required to raise.
A Seed Healthcare Biotech financial model should cover 3 years (monthly for Year 1, quarterly for Years 2-3) of projections with these tabs: Assumptions Dashboard, Revenue Cohort Model, Unit Economics, Headcount Plan, P&L Summary, Cash Flow Forecast, Series A Bridge. Path to Series A metrics and the unit economics that prove the business model. Seed investors model the path from current to Series A-level KPIs.
Reimbursement-driven revenue model with payer mix, reimbursement rates, and billing collection efficiency. Model patient volume ramp separately from revenue per patient as payer mix shifts. The key revenue drivers are: Patient volume x reimbursement rate by payer class; Commercial payer revenue (higher reimbursement); Medicare/Medicaid revenue (standardized rates); Enterprise health system contract revenue.
Healthcare Biotech unit economics at the Seed stage should include: Revenue per patient by payer type; Cost to serve per patient (clinical + overhead); Contribution margin per patient at break-even; Patient acquisition cost via provider referral; Prior authorization denial rate and cost impact. Healthcare models must show revenue cycle efficiency separately from clinical cost. Investors want to see AR days trend, denial rate trend, and payer mix shift over time — not just blended revenue per patient.
Seed models should have a clearly documented assumption page. Every assumption should include a source (comparable company benchmark, customer interview data, or market research). Avoid top-down market share assumptions. Start with the smallest unit of your business (one customer, one transaction, one seat) and build up from there. Every assumption should have a source or benchmark you can defend in an investor meeting.
Show base case (on-plan), downside (50% of plan), and recovery timeline from downside. Include a Series A readiness milestone tracker showing the KPIs required to raise.
Get the Healthcare Biotech Seed financial model as a pre-built Excel and Google Sheets template. Assumptions dashboard, revenue model, unit economics, and cash flow — ready to customize.
Includes Excel file, Google Sheets version, and model documentation guide